Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Luisa F. Duque-Buitrago, Antonio Tornero-Martínez, Verónica Loera-Castañeda & Rosalva Mora-Escobedo. (2023) Use of food and food-derived products in the treatment of gastritis: A systematic review. Critical Reviews in Food Science and Nutrition 63:22, pages 5771-5782.
Read now
Read now
Gianpiero Manes & Antonio Balzano. (2004) Tinidazole: from protozoa to Helicobacter pylori – the past, present and future of a nitroimidazole with peculiarities. Expert Review of Anti-infective Therapy 2:5, pages 695-705.
Read now
Read now
V. Ellenrieder, W. Boeck, C. Richter, R. Marre, G. Adler, B. Glasbrenner. (1999) Prevalence of Resistance to Clarithromycin and Its Clinical Impact on the Efficacy of Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 34:8, pages 750-756.
Read now
Read now
J Holton, C Besset, P Youinou & D Vaira. (1998) Emerging therapeutic targets in the eradication of Helicobacter pylori. Emerging Therapeutic Targets 2:2, pages 107-123.
Read now
Read now
H. Petersen, P. Kristensen, T. Johannessen, P. M. Kleveland, J. H. Dybdahl & H. Myrvold. (1995) The Natural Course of Peptic Ulcer Disease and its Predictors. Scandinavian Journal of Gastroenterology 30:1, pages 17-24.
Read now
Read now
R. J. Adamek, M. Freitag, W. Opferkuch, G. H. Rühl & M. Wegener. (1994) Intravenous Omeprazole/Amoxicillin and Omeprazole Pretreatment in Helicobacter pylori-Positive Acute Peptic Ulcer Bleeding: A Pilot Study. Scandinavian Journal of Gastroenterology 29:10, pages 880-883.
Read now
Read now
Articles from other publishers (67)
Kaihao Lin, Lifang Huang, Yadong Wang, Kangkang Li, Yuanning Ye, Siqi Yang & Aimin Li. (2023)
Efficacy of genotypic susceptibility‐guided tailored therapy for
Helicobacter pylori
infection: A systematic review and single arm meta‐analysis
. Helicobacter 28:6.
Crossref
Crossref
Pedro N. Sousa Sampaio & Cecília R. C. Calado. (2022) Antimicrobial evaluation of the Cynara cardunculus extract in Helicobacter pylori cells using mid-infrared spectroscopy and chemometric methods. Journal of Applied Microbiology 133:3, pages 1743-1756.
Crossref
Crossref
Yanmei Yang, Lijun Bian, Xudong Hang, Caiwang Yan, Yan Huang, Feng Ye, Guoxin Zhang, Guangfu Jin & Hongkai Bi. (2020) In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China. Diagnostic Microbiology and Infectious Disease 98:3, pages 115129.
Crossref
Crossref
Musa Marimani. 2020. Combination Therapy Against Multidrug Resistance. Combination Therapy Against Multidrug Resistance
39
64
.
Estelle Guiard, Bénédicte Lelievre, Magali Rouyer, Frank Zerbib, Bertrand Diquet, Francis Mégraud, François Tison, Emmanuelle Bignon, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore & Patrick Blin. (2019) Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study. Drug Safety 42:8, pages 993-1003.
Crossref
Crossref
James A. Ayukekbong, Michel Ntemgwa & Andrew N. Atabe. (2017) The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial Resistance & Infection Control 6:1.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
989
997
.
Peter Malfertheiner, Alexander Link & Michael Selgrad. (2014) Helicobacter pylori: perspectives and time trends. Nature Reviews Gastroenterology & Hepatology 11:10, pages 628-638.
Crossref
Crossref
Morris O. Makobongo, Jeremy J. Gilbreath & D. Scott Merrell. (2014) Nontraditional therapies to treat Helicobacter pylori infection. Journal of Microbiology 52:4, pages 259-272.
Crossref
Crossref
Morris O. Makobongo, Leo Einck, Richard M. Peek & D. Scott Merrell. (2013) In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori. PLoS ONE 8:7, pages e68917.
Crossref
Crossref
Najafi Mehri, Eftekhari Kambiz, Khodadad Ahmad, Farahmand Fatemeh, Motamed Farzaneh, Fallahi Gholam Hossein & Mahjoub Fatemeh. (2011) The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children. Arab Journal of Gastroenterology 12:1, pages 37-39.
Crossref
Crossref
A. SACHDEVA & J. NAGPAL. (2009)
Meta-analysis: efficacy of bovine lactoferrin in
Helicobacter pylori
eradication
. Alimentary Pharmacology & Therapeutics 29:7, pages 720-730.
Crossref
Crossref
Fumiko Morihara, Emi Hifumi, Manabu Yamada, Akira Nishizono & Taizo Uda. (2008)
Therapeutic effects of molecularly designed antigen UREB138 for mice infected with
Helicobacter pylori
. Biotechnology and Bioengineering 100:4, pages 634-643.
Crossref
Crossref
Fumiko Morihara, Ryoji Fujii, Emi Hifumi, Akira Nishizono & Taizo Uda. (2007) Effects of vaccination by a recombinant antigen ureB138 (a segment of the β-subunit of urease) against Helicobacter pylori infection. Journal of Medical Microbiology 56:6, pages 847-853.
Crossref
Crossref
J. L. TONG, Z. H. RAN, J. SHEN, C. X. ZHANG & S. D. XIAO. (2006) Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Alimentary Pharmacology & Therapeutics 25:2, pages 155-168.
Crossref
Crossref
Mansoor M. Amiji. (2006) Tetracycline-containing Chitosan Microspheres for Local Treatment of Helicobacter pylori Infection. Cellulose 14:1, pages 3-14.
Crossref
Crossref
Brennan M. R. Spiegel, Chiun-Fang Chiou & Joshua J. Ofman. (2005) Minimizing complications from nonsteroidal antiinflammatory drugs: Cost-effectiveness of competing strategies in varying risk groups. Arthritis & Rheumatism 53:2, pages 185-197.
Crossref
Crossref
Shi Li, Zhang Yijun, Chen Jie & Hou Xiaohua. (2004) Cloning of the gene encoding urease subunit a in helicobacter pylori. Journal of Huazhong University of Science and Technology [Medical Sciences] 24:1, pages 22-24.
Crossref
Crossref
Minhu Chen, Jie Chen, Wenjun Liao, Senlin Zhu, Jun Yu, Wai K. Leung, Pinjin Hu & Joseph J. Y. Sung. (2003) Immunization with Attenuated Salmonella typhimurium Producing Catalase in Protection against Gastric Helicobacter pylori Infection in Mice. Helicobacter 8:6, pages 613-625.
Crossref
Crossref
Audun Berstad & Per Brandtzaeg. 2003. International Handbook of Foodborne Pathogens. International Handbook of Foodborne Pathogens.
Jaime Natan Eisig, Suraia Boaventura André, Fernando Marcuz Silva, Cláudio Hashimoto, Joaquim Prado Pinto Moraes-Filho & Antonio Atilio Laudanna. (2003) The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. Arquivos de Gastroenterologia 40:1, pages 55-60.
Crossref
Crossref
P. Malfertheiner, U. Peitz & G. Treiber. 2003. Helicobactor pylori. Helicobactor pylori
391
400
.
U. Ladabaum, W. D. Chey, J. M. Scheiman & A. M. Fendrick. (2002) Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis. Alimentary Pharmacology & Therapeutics 16:8, pages 1491-1501.
Crossref
Crossref
Brennan M.R. Spiegel, Nimish B. Vakil & Joshua J. Ofman. (2002) Dyspepsia management in primary care: A decision analysis of competing strategies. Gastroenterology 122:5, pages 1270-1285.
Crossref
Crossref
Fernando Marcuz Silva, Jaime Natan Eisig, Ethel Zimberg Chehter, Júlio Jovino da Silva & Antonio Atílio Laudanna. (2002) Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. Revista do Hospital das Clínicas 57:1, pages 9-14.
Crossref
Crossref
A. Bühling, D. Radun, W. A. Müller & P. Malfertheiner. (2001)
Influence of anti-
Helicobacter
triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora
. Alimentary Pharmacology & Therapeutics 15:9, pages 1445-1452.
Crossref
Crossref
Jang-Seong Kim, Ji-Hoon Chang, Soo-Il Chung & Jung-Sun Yum. (2001)
Importance of the host genetic background on immune responses to
Helicobacter pylori
infection and therapeutic vaccine efficacy
. FEMS Immunology & Medical Microbiology 31:1, pages 41-46.
Crossref
Crossref
Rasool Sotudehmanesh, Reza Malekzadeh, Ali Fazel, Sadegh Massarrat, Behrooz Ziad‐Alizadeh & Mohammed Reza Eshraghian. (2001)
A randomized controlled comparison of three quadruple therapy regimens in a population with low
Helicobacter pylori
eradication rates
. Journal of Gastroenterology and Hepatology 16:3, pages 264-268.
Crossref
Crossref
R. Cantón, C. Martín de Argila, L. de Rafael & F. Baquero. (2001) Antimicrobial resistance in Helicobacter pylori. Reviews in Medical Microbiology 12:1, pages 47-61.
Crossref
Crossref
C. Calabrese, G. Di Febo, A. Areni, C. Scialpi, G. Biasco & M. Miglioli. (2002)
Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 14:12, pages 1613-1617.
Crossref
Crossref
Cynthia W. Ko & Richard A. Deyo. (2000) Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. Journal of General Internal Medicine 15:6, pages 400-410.
Crossref
Crossref
Melissa Rich, James M. Scheiman, William Tierney & A. Mark Fendrick. (2000) Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori"Test and Treat" strategy for patients with suspected peptic ulcer disease?. The American Journal of Gastroenterology 95:3, pages 651-658.
Crossref
Crossref
Peter Malfertheiner, Andreas Leodolter & Ulrich Peitz. (2000) Cure of Helicobacter pylori -associated ulcer disease through eradication. Best Practice & Research Clinical Gastroenterology 14:1, pages 119-132.
Crossref
Crossref
Amanda Henry & Robert G Batey. (1999) Enhancing Compliance Not A Prerequisite for Effective Eradication of Helicobacter Pylori : The Help Study. American Journal of Gastroenterology 94:3, pages 811-815.
Crossref
Crossref
Fu-Chen Huang, Mei-Hwei Chang, Hong-Yuan Hsu, Ping-Ing Lee & Chia-Tung Shun. (1999) Long-term Follow-up of Duodenal Ulcer in Children Before and After Eradication of Helicobacter pylori. Journal of Pediatric Gastroenterology & Nutrition 28:1, pages 76-80.
Crossref
Crossref
Marcia Samada Suárez, Juan González Cansino, Cira Velasco Ilizalde, Carlos Alfonso Sabatier & Juan Castillo Hernández. (1999) Three Treatment Schemes with Colloidal Bismuth Subcitrate (Q-ULCER) in Peptic Ulcer with Helicobacter pylori. Archives of Medical Research 30:1, pages 55-59.
Crossref
Crossref
B. D. Gold. 1999. Gastroduodenal Disease and Helicobacter pylori. Gastroduodenal Disease and Helicobacter pylori
71
102
.
Peter Malfertheiner. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors
173
191
.
Maria Teresa Fera, Maria Carbone, Angela De Sarro, Giovanna Blandino, Giuseppe Riggio, Vitaliano Cusumano, Giovanni Battista De Sarro & Federico Anzani Ciliberti. (1998) Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. International Journal of Antimicrobial Agents 10:4, pages 285-289.
Crossref
Crossref
Nancy Fox Ray, Mae Thamer & Scott C. Henderson. (1998) Adoption of New Pharmacotherapeutic Regimens: Analysis of Physician Prescribing for Peptic Ulcer Disease. Drug Information Journal 32:4, pages 1119-1131.
Crossref
Crossref
Frank L. Lanza, Stephen J. Sontag, Arthur A. Ciociola, Deborah L. Sykes, Amy Heath & David J. McSorley. (2001) Ranitidine Bismuth Citrate Plus Clarithromycin: A Dual Therapy Regimen for Patients with Duodenal Ulcer. Helicobacter 3:3, pages 212-221.
Crossref
Crossref
Harry Kleanthous, Gwendolyn A. Myers, Kathleen M. Georgakopoulos, Timothy J. Tibbitts, Jennifer W. Ingrassia, Heather L. Gray, Ru Ding, Zhen-Zi Zhang, Wende Lei, Richard Nichols, Cynthia K. Lee, Thomas H. Ermak & Thomas P. Monath. (1998)
Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against
Helicobacter pylori
Infection
. Infection and Immunity 66:6, pages 2879-2886.
Crossref
Crossref
Ohkusa, Takashimizu, Fujiki, Araki, Ariake, Shimoi, Honda, Enomoto, Sakurazawa, Horiuchi, Suzuki, Ishii & Ishikura. (2001) Prospective evaluation of a new anti‐ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 12:5, pages 457-461.
Crossref
Crossref
Yoshihiro Ikeda, Ryoji Fujii, Keiki Ogino, Keigo Fukushima, Emi Hifumi & Taizo Uda. (1998) Immunological features and inhibitory effects on enzymatic activity of monoclonal antibodies against Helicobacter pylori urease. Journal of Fermentation and Bioengineering 86:3, pages 271-276.
Crossref
Crossref
P. Ghiara & M. Marchetti. 1998. Symposium in Immunology VII. Symposium in Immunology VII
81
90
.
P Ghiara, M Rossi, M Marchetti, A Di Tommaso, C Vindigni, F Ciampolini, A Covacci, J L Telford, M T De Magistris, M Pizza, R Rappuoli & G Del Giudice. (1997) Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infection and Immunity 65:12, pages 4996-5002.
Crossref
Crossref
Indrajit Tiwari, Zia Mazhar, Wasim Uddin & Peter J.H. Fletcher. (1997)
Comparison of Dual and Triple Therapy for the Eradication of
Helicobacter pylori
in Duodenal Ulcer Patients
. Annals of Saudi Medicine 17:6, pages 656-658.
Crossref
Crossref
Akira Gotoh, Yoshiyuki Kawakami, Taiji Akamatsu & Tsutomu Katsuyama. (2013)
Interaction of Drugs for Eradication Therapy against Antibiotic‐Resistant Strains of
Helicobacter pylori
. Microbiology and Immunology 41:11, pages 865-869.
Crossref
Crossref
UWE BLECKER & BENJAMIN D. GOLD. (1997) Treatment of Helicobacter pylori infection: a review. The Pediatric Infectious Disease Journal 16:4, pages 391-399.
Crossref
Crossref
STUART L HAZELL, GEORGE DASKALOPOULOUS, HAZEL M MITCHELL & DAN MASSEY. (2008)
Lansoprazole and amoxycillin: Observations on the treatment of
Helicobacter pylori
infection
. Journal of Gastroenterology and Hepatology 12:2, pages 93-99.
Crossref
Crossref
Paolo Ghiara. 1997. Vaccine Design. Vaccine Design
59
66
.
Fiona J. Radcliff, Minhu Chen & Adrian Lee. (1996) Protective immunization against Helicobacter stimulates long-term immunity. Vaccine 14:8, pages 780-784.
Crossref
Crossref
Uwe Blecker, Naveen K. Mittal & Devendra I. Mehta. (1996) Presentation and management ofHelicobacter pylori infection in childhood. The Indian Journal of Pediatrics 63:3, pages 335-348.
Crossref
Crossref
Uwe Blecker. (2016) Helicobacter pylori Disease in Childhood. Clinical Pediatrics 35:4, pages 175-183.
Crossref
Crossref
L KongJ G SmithD BramhillG K AbruzzoC BonfiglioC CioffeA M FlatteryC J GillL LynchP M ScottL SilverC ThompsonH KroppK Bartizal. (1996) A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model. Clinical Diagnostic Laboratory Immunology 3:1, pages 73-78.
Crossref
Crossref
John CalamJohn Calam. 1996. Clinicians’ Guide to Helicobacter pylori. Clinicians’ Guide to Helicobacter pylori
117
150
.
Adam W. Harris & J.J. Misiewicz. (1995) 10 Eradication of Helicobacter pylori. Baillière's Clinical Gastroenterology 9:3, pages 583-613.
Crossref
Crossref
R. P. H. LOGAN, K. D. BARDHAN, L. R. CELESTIN, A. THEODOSSI, K. R. PALMER, P. I. REED, J. H. BARON & J. J. MISIEWICZ. (2007)
Eradication of
Helicobacter pylori
and prevention of recurrence of duodenal ulcer: a randomized, double‐blind, multi‐centre trial of omeprazole with or without clarithromycin
. Alimentary Pharmacology & Therapeutics 9:4, pages 417-423.
Crossref
Crossref
Irène Corthésy-Theulaz, Nadine Porta, Micheline Glauser, Emilia Saraga, Anne-Catherine Vaney, Rainer Haas, Jean-Pierre Kraehenbuhl, AndréL. Blum & Pierre Michetti. (1995) Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 109:1, pages 115-121.
Crossref
Crossref
Margaret Fitzgerald, Lisa Berg‐Gulcher & Margaret Fitzgerald. (2007) Pharmacologic Highlights. Journal of the American Academy of Nurse Practitioners 7:5, pages 233-235.
Crossref
Crossref
J. C. Pechère. 1995. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine
473
481
.
Rudolf Hatz, Ekkehard Bayerdörffer, Norbert Lehn & Georg Enders. (2012) Immune Response in Helicobacter pylori Infection. Clinical Immunotherapeutics 2:4, pages 295-306.
Crossref
Crossref
M. C. Bateson. (1994) Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.. Postgraduate Medical Journal 70:826, pages 561-567.
Crossref
Crossref
. (1994) Ranitidine and Recurrent Hemorrhage from Duodenal Ulcer. New England Journal of Medicine 331:1, pages 53-54.
Crossref
Crossref
Jean-Claude Péchère. (1994) Antibiotic Resistance Is Selected Primarily in Our Patients. Infection Control and Hospital Epidemiology 15:7, pages 472-477.
Crossref
Crossref
J.M. Arnau & A. Vallano. 1994.
370
379
.
M. Pirmohamed & P.A. Winstanley. 1994.
286
298
.